University of Colorado Hospital Anschutz Cancer Pavilion — Aurora, Colorado

University of Colorado Hospital Anschutz Cancer Pavilion is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Colorado Hospital Anschutz Cancer Pavilion has participated in 61 clinical trials with 23 currently active.

Therapeutic areas: Colorectal Cancer, mCRPC, Melanoma.

Sponsors: Lyell Immunopharma, Inc., Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Aurora

Browse all research sites in Colorado · View every site in Aurora

Sponsor Feasibility Report

Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Hospital Anschutz Cancer Pavilion?

University of Colorado Hospital Anschutz Cancer Pavilion has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Hospital Anschutz Cancer Pavilion conducted?

University of Colorado Hospital Anschutz Cancer Pavilion has 61 clinical trials on record, with 23 currently active. Their work covers Colorectal Cancer, mCRPC, Melanoma.

Is University of Colorado Hospital Anschutz Cancer Pavilion accredited by Crixeo Clinical Trials?

University of Colorado Hospital Anschutz Cancer Pavilion has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Hospital Anschutz Cancer Pavilion?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.